Publication
International arbitration report
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
US: It’s time to reconsider poison pill strategies
When stock prices drop for reasons unrelated to company fundamentals, those companies are vulnerable to opportunistic activists and potential unsolicited acquirors, who can otherwise acquire a large stake before filing a Schedule 13D or 13G or HSR Form. In addition, the CARES Act has provided for enhanced NOL carryback opportunities for some companies, increasing the need to protect their NOL assets. In both cases, companies need to consider measures to protect their shareholders to enable them to benefit from the return to more normal share prices or to realize the value of their NOL assets. In fact, 2020 has already seen a significant uptick in preemptive standard and NOL pill adoption.
View key areas public company boards should consider in the current environment.
Senior Associate
Email
amelia.zhang@nortonrosefulbright.com
Recent publications
Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .